chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: I have premature ovarian failure so in menopause for the last 2.5 years. 3days after the second dose of vaccine I experienced heavy vaginale bleeding like menstruation for at least 7days (still ongoin; This is a spontaneous report from a contactable other hcp (Patient) reporting for herself.  A 41-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: ER8729), dose 2 via an unspecified route of administration, administered in Arm Right on 04Apr2021 at 14:30 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included premature menopause from an unknown date and unknown if ongoing, at 35 years old have premature ovarian failure so in menopause for the last 2.5 years, premature menopause from an unknown date and unknown if ongoing at 35 years old, gluten sensitivity from an unknown date and unknown if ongoing Known allergies: Gluten. Concomitant medication included estradiol (ESTRADIOL TRANSDERMAL) taken for an unspecified indication, start and stop date were not reported. It was reported that, the patient has premature ovarian failure so in menopause for the last 2.5 years. 3days after the second dose of vaccine, on 07Apr2021 at 02:00, patient experienced heavy vaginal bleeding like menstruation for at least 7days. Stated that, it is still ongoing but decreased intensity. Outcome for the events was recovering.  Follow-up attempts are completed. No further information expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Fatigue, Headache, Muscular weakness
Clinical narrative: low grade fever; severe muscle aches; fatigue; runny nose; wheezing cough; headache; swollen arm; weakness in extremities; nausea; blurred vision; dizziness; cough; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heartbeats irregular and cardiac ablation. The patient received other medications within two weeks of vaccination, names unspecified. The patient previously took codeine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00, the patient experienced low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Peripheral swelling, Pyrexia, Rhinorrhoea
Clinical narrative: low grade fever; severe muscle aches; fatigue; runny nose; wheezing cough; headache; swollen arm; weakness in extremities; nausea; blurred vision; dizziness; cough; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heartbeats irregular and cardiac ablation. The patient received other medications within two weeks of vaccination, names unspecified. The patient previously took codeine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00, the patient experienced low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: low grade fever; severe muscle aches; fatigue; runny nose; wheezing cough; headache; swollen arm; weakness in extremities; nausea; blurred vision; dizziness; cough; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heartbeats irregular and cardiac ablation. The patient received other medications within two weeks of vaccination, names unspecified. The patient previously took codeine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00, the patient experienced low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymph node pain, Lymphadenopathy
Clinical narrative: armpits were tender; lump node on left collarbone that swelled and became painful.; lump node on left collarbone that swelled and became painful.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 05Apr2021 at 11:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 07:00 the patient experienced her armpits were tender and she had a lump node on her left collarbone that swelled and became painful. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events armpits were tender and lump node on left collarbone that swelled and became painful was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia
Clinical narrative: On Saturday night, April 10th, at bedtime I started to feel muscle pains in my hamstrings. The pain subsided a little during the day of Monday, April 12th, but the pain returned in the middle of the night.; extremely difficult to fall asleep; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 08Apr2021 at 11:15(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included vitamins nos (MULTIVITAMINS), red yeast rice (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN). Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 Saturday night at 01:00 at bedtime, the patient started to feel muscle pains in hamstrings, extremely difficult to fall asleep. The pain subsided a little during the day of Monday 12Apr2021, but the pain returned in the middle of the night. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event on Saturday night, at bedtime started to feel muscle pains in hamstrings not extremely difficult to fall asleep the pain subsided a little during the day of Monday, but the pain returned in the middle of the night were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: overall minor body aches after second dose; This is a spontaneous report from a contactable consumer. A 18-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 12Apr2021 at 09:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 9:30 as a single dose. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 10:00, the patient experienced overall minor body aches after the second dose. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event overall minor body aches was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on right arm and ribcage; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8737) via an unspecified route of administration in the arm right on an unknown date in Apr2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient received medications (unspecified) within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Apr2021, the patient experienced shingles on right arm and ribcage. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles on right arm and ribcage which included treatment with FAMOVIR on an unspecified date. The clinical outcome of the event shingles on right arm and ribcage was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chest discomfort, Fatigue, Headache
Clinical narrative: Temp running 100 to 102; headache; sore throat; body hurts; extreme fatique; chest feels congested; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8732) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 18Mar2021 at 07:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 20:00, the patient experienced temp running 100 to 102, headache, sore throat, body hurts, extreme fatigue, chest feels congested. On 12Apr2021, the patient underwent Body temperature measurement and the result was 100 to 102 (UNSPECIFIED UNITS). The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events temp running 100 to 102, headache, sore throat, body hurts, extreme fatigue, chest feels congested was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain
Clinical narrative: Temp running 100 to 102; headache; sore throat; body hurts; extreme fatique; chest feels congested; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8732) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 18Mar2021 at 07:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 20:00, the patient experienced temp running 100 to 102, headache, sore throat, body hurts, extreme fatigue, chest feels congested. On 12Apr2021, the patient underwent Body temperature measurement and the result was 100 to 102 (UNSPECIFIED UNITS). The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events temp running 100 to 102, headache, sore throat, body hurts, extreme fatigue, chest feels congested was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Eye pain, Headache, Pain assessment, Pyrexia
Clinical narrative: Fever of 100 F; Soreness at injection site; Pounding headache in eye, entire top left side of head, 8/10 pain; Pounding in eye; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 17:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included slufa drug (sulfonamide) allergy and protein s deficiency. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 17:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 23:00, the patient experienced a fever of 100 F (Fahrenheit), soreness at injection site and pounding headache in eye, entire top left side of head, 8/10 pain. Since the vaccination, the patient had not been tested for COVID-19. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever of 100 F, soreness at injection site and pounding headache in eye, entire top left side of head, 8/10 pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever of 100 F; Soreness at injection site; Pounding headache in eye, entire top left side of head, 8/10 pain; Pounding in eye; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 17:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included slufa drug (sulfonamide) allergy and protein s deficiency. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 17:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 23:00, the patient experienced a fever of 100 F (Fahrenheit), soreness at injection site and pounding headache in eye, entire top left side of head, 8/10 pain. Since the vaccination, the patient had not been tested for COVID-19. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever of 100 F, soreness at injection site and pounding headache in eye, entire top left side of head, 8/10 pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen under arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 10Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin, seasonal allergies and apple. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced swollen under arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen under arm was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Bitter taste in mouth with or without food/drinks; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150), via an unspecified route of administration in the left arm on 03Apr2021 at 11:45(at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had a history of allergies to penicillin and IV dye and Percocet. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), vitamin d nos (VITAMIN D), vitamin b12 nos (VITAMIN B12) and chondroitin sulfate, glucosamine (MOVE FREE) all taken for unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 13:00, the patient had bitter taste in mouth with or without food or drinks. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event bitter taste in mouth with or without food or drinks was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Musculoskeletal stiffness
Clinical narrative: Stiff neck; Little headed a couple of times; Tired; Major headache; Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 11Apr2021 at 14:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The clinical outcome of the events tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times were resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Stiff neck; Little headed a couple of times; Tired; Major headache; Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 11Apr2021 at 14:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The clinical outcome of the events tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times were resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: fever; fatigue; injection site pain; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a female patient(wife) of unknown age who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 08Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in 2021 the patient had mild fever, fatigue and injection site pain after receiving the vaccine. The event outcome was unknown  No follow-up attempts were needed; information about lot/batch number could not be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on chest; This is a spontaneous report from a contactable consumer, the patient. A male patient of unknown age received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown if patient received any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021, the patient experienced rash on chest appeared after receiving vaccine and it was gone the next morning. It was unknown if patient received any treatment for the adverse event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event rash on chest was resolved on 13Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, SARS-CoV-2 test, Vomiting
Clinical narrative: nausea; vomiting; diahreaa; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 13:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included estrogen (MANUFACTURER UKNNOWN), progesterone (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 03:00 the patient experienced nausea, vomiting and diarrhoea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 24Mar2021, the patient underwent COVID-19 PCR (nasal swab) test and the result was negative. The clinical outcome of the events nausea, vomiting and diarrhoea were not recovered at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 13:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8731) via an unspecified route of administration in the left arm on 13Apr2021 at 10:30 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, since unknown date. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol tartrate (METOPROLOL) 50 mg, losartan 100 mg (MANUFACTURER UNKNOWN), all on unknown date, for unknown indication and unknown if ongoing. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6207) via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. On 13Apr2021 at 11:30, the patient experienced vomiting. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomiting was recovered on 13Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Breast swelling, Decreased appetite, Fatigue
Clinical narrative: High heart rate high while sleeping; Joint stiffness whole body; Hot; Cold; Armpit pain left side; Swollen left breast; Armpit Swelling (left side); Swollen neck (left side); Night sweats; Loss of appetite; Swollen face left side; Fever; Exhausted; Joint pain whole body; Arm pain (whole left arm); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome, major depression and anxiety, since unknown date. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included VIIBRYD, metformin (MANUFACTURER UNKNOWN), Prenatal vitamins (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), VITAMIN B6 and VITAMIN B12 (MANUFACTURER UNKNOWN), all on unknown date, for unknown indications and unknown if ongoing. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 19Mar2021 at 17:15 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 11Apr2021 at 00:00, the patient experienced high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Feeling hot, Heart rate, Heart rate increased, Joint stiffness
Clinical narrative: High heart rate high while sleeping; Joint stiffness whole body; Hot; Cold; Armpit pain left side; Swollen left breast; Armpit Swelling (left side); Swollen neck (left side); Night sweats; Loss of appetite; Swollen face left side; Fever; Exhausted; Joint pain whole body; Arm pain (whole left arm); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome, major depression and anxiety, since unknown date. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included VIIBRYD, metformin (MANUFACTURER UNKNOWN), Prenatal vitamins (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), VITAMIN B6 and VITAMIN B12 (MANUFACTURER UNKNOWN), all on unknown date, for unknown indications and unknown if ongoing. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 19Mar2021 at 17:15 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 11Apr2021 at 00:00, the patient experienced high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Pain in extremity, Pyrexia, Swelling, Swelling face
Clinical narrative: High heart rate high while sleeping; Joint stiffness whole body; Hot; Cold; Armpit pain left side; Swollen left breast; Armpit Swelling (left side); Swollen neck (left side); Night sweats; Loss of appetite; Swollen face left side; Fever; Exhausted; Joint pain whole body; Arm pain (whole left arm); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome, major depression and anxiety, since unknown date. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included VIIBRYD, metformin (MANUFACTURER UNKNOWN), Prenatal vitamins (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), VITAMIN B6 and VITAMIN B12 (MANUFACTURER UNKNOWN), all on unknown date, for unknown indications and unknown if ongoing. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 19Mar2021 at 17:15 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 11Apr2021 at 00:00, the patient experienced high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events high heart rate high while sleeping, fever, night sweats, joint pain stiffness whole body, exhausted, hot/cold, loss of appetite, arm pain (whole left arm), armpit pain and swelling (left side), swollen face/neck (left side) and swollen left breast were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Menstruation delayed, Pain, Pyrexia
Clinical narrative: Period was 8 days late.; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; "relatively robust immune response after the second dose (body aches, fever, chills, dizziness)"; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 25Mar2021 at 18:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included IMPLANON for birth control since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, after receiving the second dose, the patient's period was 8 days late. The patient had been diligently tracking her period for over 3 years and had a 28 day cycle on the dot every month with no period arriving early or late. She had a relatively robust immune response after the second dose (body aches, fever, chills, dizziness). The vaccine was the only change to her body that she able to isolate that would have affected her cycle. There were no other changes in her diet, habits or stress levels at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events period was 8 days late and "robust immune response after the second dose (body aches, fever, chills, dizziness)" were resolved on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Acne pustular, Erythema, Pain, Rash, Skin warm
Clinical narrative: Red cheeks and chin,hot to the touch; Face rash - acne/chicken pox like some with pus. Red cheeks and chin, hot to the touch, painful.; Acne/chicken pox like some with pus; Red cheeks and chin, hot to the touch; Red cheeks and chin,hot to the touch, painful.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 11Apr2021 at 17:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, severe back pain and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), salbutamol (albuterol) (MANUFACTURER UNKNOWN), vitamin C (MANUFACTURER UNKNOWN and vitamin D (MANUFACTURER UNKNOWN). On 12Apr2021 at 13:00, the patient experienced face rash, acne/chicken pox like some with pus, red cheeks and chin, hot to the touch and painful. Therapeutic measures were taken as a result of the events, face rash, acne/chicken pox like some with pus, red cheeks and chin, hot to the touch and painful, which included treatment with cortisone applied to the affected areas. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination the patient not been tested for COVID-19. The clinical outcome of the events face rash, acne/chicken pox like some with pus, red cheeks and chin, hot to the touch and painful were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Tinnitus, Vertigo
Clinical narrative: Vertigo; Dizziness; Headache; Tinnitus; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included eczema, obesity, sleep apnea, birth control, seasonal allergies, pollen allergy, dust allergy and mildew allergy. Concomitant medications included ethinylestradiol; norethisterone acetate (JUNEL) for birth control from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced vertigo, dizziness, headache, tinnitus and brain fog. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events vertigo, dizziness, headache, tinnitus and brain fog were resolving, at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Aching pain in right armpit; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies to medications, food and other products. Concomitant medications included ethinylestradiol, norelgestromin (XULANE); from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 08:30, the patient experienced aching pain in right armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event aching pain in right armpit was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.